Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Eyenovia (EYEN) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 12 quarters since 2018. Compare with EYEN stock chart to see long term trends.

EYEN stock compared to

EYEN Income Statement

Research & Development Expense:3350521
Total Operating Expenses:5406618
Operating Income:-4206618
Net Income:-4206862
Earnings Per Share, Basic:-0.15
Shares Outstanding, Basic Avg:21054706

EYEN Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:23787
Net Cash from Operations:5469093
Net Cash from Financing Activities:97368
Property, Plant & Equipment Purchases:59211
Net Cash from Investing Activities:-59211
Net Change in Cash & Equivalents:5507250

EYEN Balance Sheet

Cash and Cash Equivalents:28371828
Total Current Assets:33391345
Property, Plant & Equipment, Net:396380
Total Assets:33906760
Accounts Payable:1461665
Total Short-Term Liabilities:18198377
Total Liabilities:18602875

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Sabby Management, LLC
608,720 sh
608,720 sh
Vanguard Group Inc
413,221 sh
210,912 sh
Renaissance Technologies LLC
97,200 sh
76,400 sh
Blackrock Inc.
49,255 sh
5,257 sh
Northern Trust Corp
24,274 sh
Virtu Financial LLC
16,456 sh
16,456 sh
Bank Of America Corp /De/
10,000 sh
Morgan Stanley
3,000 sh
-2,000 sh
Royal Bank Of Canada
2,881 sh
9 sh
Proequities, Inc.
0 sh

Data imported from Eyenovia Inc SEC filings. Check original filings before making any investment decision.